They haven't gone silent, they've just released the report and confirmed their commercialisation strategy! Which, for clarity, is centered around cardio protection with anti-cancer synergy, and the sales pipeline has been estimated based on synergies with anthracyclines.
We know there are data being held for legitimate IP protection reasons. And we know that negative results don't drive that action.
Breast cancer trial getting underway.
I can't explain the lack of interest but I can point to the fact that until it's a competitive field, they can try to develop their own and play "wait and see". And I can point to plenty of other forums who think we (RAC investors) are crazy, I'm betting they're wrong.
Ann: Race releases complete cardio-protection data & video, page-95
-
- There are more pages in this discussion • 142 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |